Actionable metastatic cancer genome is remarkably stable over time, despite treatment with drugs

A one-time analysis of the entire tumor DNA is almost always sufficient to find all DNA errors that may be relevant for treating metastatic cancer. This is because actionable DNA errors remain remarkably stable over time, despite treatment with drugs. This discovery was made by Dutch researchers in a study led by the Netherlands Cancer Institute. The researchers used data from the Hartwig Medical Database for their research. They published their findings on August 9 online in the scientific journal Nature Medicine.

More information

You read an article in the category OncoAct. You may also be interested in Research, Scientific publications or Whole genome sequencing.
All news

Also read

Whole genome sequencing to improve individual cancer treatment in Finland

Whole genome sequencing to improve individual cancer treatment in Finland

10-07-2020

Since August 2019, Docrates, a private cancer center in Finland, uses the whole genome sequencing test from Hartwig Medical Foundation to …

SAGE: New algorithm for analysis of tumor DNA reveals mutations previously not found

SAGE: New algorithm for analysis of tumor DNA reveals mutations previously not found

23-07-2020

At Hartwig we “analyse sequenced tumor DNA”. This is something we try to continuously improve. These analyses are shared with …

New CPoC grant awarded: GLOW – GLioblastoma targeted treatment Option maximisation by WGS

New CPoC grant awarded: GLOW – GLioblastoma targeted treatment Option maximisation by WGS

27-05-2021

Oncode Institute has announced that the 13th grant within the Clinical Proof of Concept programme has been awarded. Oncode Investigator …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl